<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Breast cancer":13,
"Chemotherapy":2,
"HCV reactivation":1,
"Hepatitis C virus (HCV)":1,
"Toxicity":1,
"68Ga-PSMA":1,
"PET/CT":1,
"prostate cancer":1,
"synchronous primary malignancy":1,
"Emergency endocrine disease":1,
"Intensive care":1,
"Pheochromocytoma multisystem crisis":1,
"Thyrotoxic crisis":1,
"Lymphangiogenesis":1,
"Lymphatic vessel density":1,
"Melanoma":2,
"Metastasis":10,
"Prediction":1,
"VEGF-C":1,
"Biopsy, fine-needle":1,
"Clinical hypothyroidism":1,
"Lymphocytic thyroiditis":1,
"Thyroid function tests":1,
"Thyroid nodule":4,
"Hodgkin lymphoma":1,
"childhood":2,
"long-term follow-up":2,
"screening recommendations":1,
"subsequent malignant neoplasm (SMN)":1,
"cancer":7,
"firefighter":1,
"firefighting":1,
"meta-analysis":4,
"review":1,
"Lingual lymph node":1,
"head and neck squamous cell carcinoma":1,
"locoregional control":1,
"prognosis":6,
"tongue squamous cell carcinoma":1,
"Extrathyroidal invasion":1,
"Lymph node metastases":1,
"Papillary thyroid carcinoma":23,
"Recurrence":4,
"Recurrence-free survival":1,
"Vascular invasion":1,
"Diffusion-weighted imaging":2,
"Elasticity imaging techniques":1,
"Neoplasms":3,
"Positron emission tomography/computed tomography":1,
"Ultrasound imaging":1,
"thyroid":11,
"3,3',5’-triiodo-L-thyronine":1,
"Integrin αvβ3":1,
"L-thyroxine":1,
"glioblastoma":1,
"breast cancer (BRCA)":1,
"long noncoding RNA":1,
"prognostic":1,
"protein-coding gene (PCG)":1,
"signature":1,
"immunocytes":1,
"molecular subtypes":1,
"peripheral blood parameter":1,
"elastography":1,
"strain ratio":1,
"thyroid cancer":26,
"thyroid nodules":6,
"ultrasound":5,
"2型糖尿病":1,
"risk":1,
"type 2 diabetes":1,
"癌症":1,
"风险":1,
"FNA":2,
"Hürthle cell":1,
"Oxyphilic cell":1,
"AKT/mTOR signaling pathway":1,
"aristaless-like homeobox 4":1,
"long intergenic non-protein coding RNA 313":1,
"proliferation":9,
"diagnosis":1,
"gynecomastia":1,
"male breast cancer":1,
"management":2,
"testosterone":1,
"LRRK2":1,
"apoptosis":2,
"autophagy":2,
"long noncoding RNA RP11-476D10 1":1,
"microRNA-138-5p":1,
"autopsy":1,
"cause of death":1,
"forensic pathology":1,
"forensic science":1,
"hepatic hemangioma":1,
"pulmonary thromboembolism":1,
"sudden collapse":1,
"EBV":1,
"herpesvirus type 4":1,
"thyroid tumor":1,
"viral load":1,
"False-negative rate":1,
"Size":1,
"Thyroid carcinoma":10,
"≥4 cm":1,
"immunohistochemistry":2,
"menin":1,
"Disease-specific survival":1,
"Lobectomy":1,
"Older adults":1,
"Papillary thyroid cancer":13,
"Surgery":2,
"Thyroidectomy":4,
"18-FDG PET-CT":1,
"Cystic adenopathy":1,
"Nasopharyngeal cancer":1,
"Oropharyngeal cancer":2,
"Thyroid papillary carcinoma":1,
"Analgesia":1,
"Postoperative pain management":1,
"TOETVA":1,
"Thyroid surgery":1,
"VAS":1,
"cabozantinib":1,
"hepatocellular carcinoma":1,
"liver dysfunction":1,
"population pharmacokinetics":1,
"Central neck dissection":1,
"Local recurrence":1,
"DNA repair":1,
"Multiple primary tumors":1,
"PARP4":1,
"PARP4P2":1,
"Pseudogene":1,
"RAP1B":1,
"invasion":5,
"miR-206":2,
"Disparity":1,
"Radioactive iodine":3,
"dermatologic toxicity":1,
"immune checkpoint inhibitor":1,
"immune-related adverse events":1,
"lichenoid dermatitis":1,
"mycosis fungoides":1,
"Athyreotic patients":1,
"Levothyroxine":1,
"Thyrotropin":1,
"Triiodothyronine":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Thyroid cytology":1,
"Thyroid ultrasound":1,
"Diabetes insipidus":1,
"Hypothalamus":1,
"Magnetic resonance imaging":2,
"Pituitary stalk sectioning":1,
"Reconstitution":1,
"Recovery":1,
"Differentiated thyroid carcinoma":1,
"Distant metastases":1,
"Multiple distant organ system metastases":1,
"Overall survival":1,
"Radioactive iodine therapy":2,
"cytology":2,
"intrathyroidal thymic carcinoma":1,
"neuroendocrine differentiation":1,
"Anatomy":1,
"Thyroid gland":4,
"Ultrasonography":5,
"SDPR":1,
"lncRNA":2,
"mechanism":1,
"tumor suppressor gene":1,
"Anaplastic thyroid carcinoma":2,
"CCL3":1,
"CCR5":1,
"MMP-1":1,
"Platelet":1,
"Breast-conserving surgery":1,
"Ductal carcinoma in situ":1,
"Postoperative radiotherapy":3,
"Afirma gene expression classifier":1,
"Hurthle cells":1,
"ThyroSeq":1,
"fine needle aspiration, thyroid cytopathology, molecular testing":1,
"indeterminate thyroid cytology":1,
"Gastroenteropancreatic neuroendocrine tumors":1,
"Imaging":1,
"Medullary thyroid cancer":2,
"Pheochromocytoma":1,
"Pituitary adenoma":1,
"Etiology":1,
"Thyroid disease":1,
"Thyroid tissue":1,
"Toxic/essential trace metals":1,
"Multiple endocrine neoplasia":1,
"Neuroendocrine tumors":1,
"Staging":1,
"Anaplastic thyroid cancer":3,
"Cytogenetic techniques":1,
"Fine-needle aspiration cytology":1,
"Genetic profile":1,
"Molecular biology":1,
"Tumor cell line":1,
"cytopathology":1,
"endocrine pathology":1,
"aberrant thyroid tissue":1,
"incidental finding":1,
"neck metastases":1,
"occult metastases":1,
"DDR1":1,
"DDR2":1,
"Discoidin domain receptors":1,
"Insulin receptor":1,
"Insulin-like growth factor system":1,
"Insulin-like growth factor-2":1,
"Isoform A":1,
"Anti-HER2 antibody":1,
"Boron neutron capture therapy":1,
"Gold nanoparticle-boron cage assemblies":1,
"Clinicopathological parameters":1,
"Neck dissection":1,
"Strap muscle":1,
"Suprasternal space lymph node":1,
"Complications":1,
"Surgical morbidity":1,
"Glycomics":1,
"Glycosylation":1,
"Mass spectrometry":1,
"N-Glycans":1,
"Ambulatoire":1,
"Chirurgie":1,
"Facteurs de risque":1,
"Outpatient":1,
"Risk factors":3,
"Thyroïde":1,
"Glycolysis":2,
"Inflammation":1,
"Metabolic diseases":1,
"Oxidants":1,
"Pyruvate kinase M2":2,
"Redox homeostasis":1,
"Warburg effect":2,
"microcarcinoma":1,
"propensity score matching":1,
"transcriptome":1,
"deglutition disorders":1,
"jaw exercise":1,
"jaw range of motion":1,
"oral cancer":1,
"quality of life":1,
"trismus":1,
"DNER":1,
"Girdin/PI3K/AKT axis":1,
"Hürthle cell carcinoma":1,
"Oncocytic":1,
"Oxyphilic papillary thyroid cancer":1,
"GLP-1 receptor agonists":1,
"Randomized controlled trials":1,
"Type 2 diabetes mellitus":1,
"CyberKnife":1,
"bone metastasis":1,
"differentiated thyroid cancer":3,
"stereotactic radiotherapy":2,
"TPO gene":1,
"congenital goiter":1,
"congenital hypothyroidism":1,
"thyroid dyshormonogenesis":1,
"active surveillance":3,
"computed tomography":1,
"lymph node metastasis":3,
"papillary thyroid microcarcinoma":5,
"cancer cure":1,
"cancer survivors":1,
"life expectancy":1,
"time to cure":1,
"Atypia of undetermined significance":1,
"Follicular lesions of undetermined significance":1,
"Mutational profile":1,
"Suspicious for malignancy":1,
"Thyroid FNA":1,
"immediate surgery":1,
"questionnaire survey":1,
"ATSP":1,
"HLRCC":1,
"PKM2":1,
"redox regulation":1,
"aerodigestive tract":1,
"extrathyroidal extension":1,
"papillary carcinoma":2,
"positive margins":1,
"ETS factors":1,
"MAPK":1,
"TERT":1,
"123I scan":1,
"124I PET/CT":1,
"131I scan":1,
"detection":1,
"APC gene mutation":1,
"CMV–PTC":1,
"FAP":1,
"multifocality":1,
"β-catenin":2,
"fine-needle aspiration":1,
"indeterminate cytology":1,
"molecular diagnostics":1,
"molecular testing":2,
"DNA methylation":1,
"Histone modification":1,
"MicroRNA":1,
"Fine-needle aspiration biopsy":1,
"Indeterminate nodule":1,
"McGill Thyroid Nodule Score":1,
"4 T1 cells":1,
"MAPK pathway":1,
"Triple-negative breast cancer":1,
"Tumor-associated macrophages":1,
"hemithyroidectomy":1,
"low-risk thyroid cancer":1,
"neck ultrasonography":1,
"thyroglobulin":3,
"total thyroidectomy":1,
"UPP1":1,
"epithelial-mesenchymal transition (EMT)":1,
"CD8":1,
"FoxP3":1,
"tumor bed":1,
"tumor stroma":1,
"cancer stem cell":1,
"epithelial-mesenchymal transition":1,
"lateral neck-node metastasis":1,
"lymphatic spread":1,
"thyroid papillary microcarcinoma":1,
"FOXF1":1,
"bioinformatic analysis":2,
"Chinese Han population":1,
"IL1A":1,
"IL1B":1,
"Polymorphisms":1,
"Adverse pathological feature":1,
"Early stage oral cavity cancer":1,
"dental X-rays":1,
"dental radiography":1,
"glioma":1,
"head and neck cancer":4,
"meningioma":1,
"systematic review":1,
"head and neck neoplasms":1,
"survival analysis":3,
"transplants":1,
"thyroid follicles":1,
"thyroid function":1,
"malignant pleural effusion":1,
"pleural thyroglobulin":1,
"BRAF":1,
"clinicopathological feature":1,
"mutation":2,
"sequence":1,
"Afirma":1,
"fine-needle aspiration (FNA)":1,
"gene expression classifier (GEC)":1,
"genomic sequencing classifier (GSC)":1,
"molecular":1,
"ALK":2,
"NIFTP":2,
"Lnc-SLC4A1-1":1,
"NF-κB/CXCL8":1,
"cancer cell metastasis":1,
"cell apoptosis":2,
"CD1d":1,
"NKT cell":1,
"immunotherapy":2,
"lymphocyte infiltration":1,
"hypothyroidism":3,
"intensity-modulated radiotherapy":1,
"nasopharyngeal carcinoma":1,
"prevalence":1,
"bilateral lateral neck metastasis":1,
"one lobe":1,
"Low-risk":1,
"Observation":1,
"Mucinous carcinoma":1,
"Ovarian carcinoma":1,
"Small-cell carcinoma":1,
"SEER":2,
"competing risk":1,
"nomogram":3,
"Monte Carlo simulation":1,
"effective dose":1,
"four-dimensional cone-beam computed tomography":1,
"secondary cancer risk":1,
"chemoradiotherapy":1,
"circulating tumor DNA":1,
"focal adhesion":1,
"liquid biopsy":1,
"whole-exome sequencing":1,
"Micro-carcinome papillaire de la thyroïde":1,
"Métastase":1,
"Proteomics":1,
"Protéomique":1,
"Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis":1,
"bioinformatics analysis":1,
"differentially expressed genes":1,
"lung cancer":1,
"protein-protein interaction":1,
"sphingosine kinase 1":1,
"survival":4,
"Biomarker testing":1,
"NTRK gene fusion":1,
"precision medicine":1,
"soft tissue sarcoma":1,
"BRAF inhibitor":1,
"MAPK inhibitor":1,
"MEK inhibitor":1,
"mitogen-activated protein kinase inhibitor":1,
"radioiodine refractory thyroid cancer":1,
"radioiodine therapy":1,
"Chronic obstructive pulmonary disease":1,
"Enolase":1,
"Neuron-specific enolase":1,
"Pulmonary alveolar proteinosis":1,
"Solitary pulmonary nodules":1,
"FOXM1":1,
"LINC01410":1,
"miR-3619-5p":1,
"llamas":1,
"CCDC6":1,
"alectinib":1,
"medullary thyroid carcinoma":3,
"pediatric":1,
"I-131 postablation scan":1,
"SPECT/CT":1,
"whole body scan":1,
"IRAK1":1,
"NFKB1":1,
"NFKBIA":1,
"mir-146a":1,
"evolution":1,
"exome sequencing":1,
"multi-tissue":1,
"phylogeny":1,
"subclonal mutations":1,
"BRAF V600E":1,
"PAX8-PPARG":1,
"RAS":1,
"American Thyroid Association guidelines":1,
"radioactive iodine ablation":1,
"Incidence":1,
"Initial manifestation of malignancy":1,
"Spinal metastasis":1,
"Surgical treatment":1,
"Alternative splicing":1,
"Curcumin":1,
"PKM":1,
"cell growth":1,
"clinicopathological characteristics":1,
"diagnostic value":1,
"microRNA-130a":1,
"microRNA-203":1,
"AKT/STAT3 signaling pathway":1,
"Competing endogenous RNA":1,
"Long non-coding RNA 01296":1,
"Musashi 2":1,
"microRNA-143-3p":1,
"PTP1B":1,
"UCA1":1,
"Follicular thyroid cancer":2,
"PTEN":1,
"Signet ring cell":1,
"NOP53":1,
"genetic abnormalities":1,
"oncogenic mutations":1,
"BRAF mutation":1,
"CHEK2 mutation":1,
"response to therapy":1,
"risk stratification":1,
"Breast neoplasms":1,
"Circulating tumor cells":1,
"Endoscopic breast surgery":1,
"Micrometastases":1,
"Neoplastic cells":1,
"Open surgery":1,
"head and neck surgery":1,
"otolaryngology / ENT":1,
"irradiation":1,
"pneumonitis":1,
"Hyperparathyroidism":1,
"Intrathyroidal parathyroid adenomas":1,
"Kidney transplantation":1,
"BRAFV600E mutations":1,
"RAS mutation":1,
"classic variant":1,
"follicular variant":1,
"genetic drivers":1,
"sonographic features":1,
"epigenetics":1,
"genetics":1,
"PROX1":1,
"angiogenesis":1,
"metabolism":1,
"migration":4,
"TKIs":1,
"Tyrosine kinase inhibitors":2,
"progression free survival":1,
"thyroid dysfunction":1,
"Enhancer of zeste homolog 2":1,
"Estrogen receptor alpha":1,
"ATC":1,
"SOCS1":1,
"miR-155":1,
"Benign thyroid nodules":1,
"DLG1-AS1":1,
"miR-199a-3p":1,
"Au nanoparticles":1,
"Dissolved oxygen":1,
"Electrochemiluminescence":1,
"G-C3N4":1,
"Glassy carbon electrode":1,
"Peroxodisulfate":1,
"Polyaniline":1,
"Ratiometric assay":1,
"Immune checkpoint inhibitors":1,
"Oligometastases":1,
"Pathologic complete response":1,
"ING4":1,
"miR-765":1,
"Ectopic mediastinal parathyroid tumor":1,
"Technetium-99 m methoxyisobutyl isonitrile scintigraphy":1,
"Video-assisted thoracoscopic surgery":1,
"Contrast media":1,
"Liver":1,
"Neoplasm metastasis":1,
"Positron emission tomography computed tomography":1,
"data analysis":1,
"trend":1,
"Cervical lymph node dissection":1,
"Cervical lymph node metastasis":1,
"thyroid malignancy":1,
"NTRK fusions":1,
"ancillary testing":1,
"next-generation sequencing":1,
"tyrosine kinase inhibitor":1,
"MTFR2":1,
"Thyroid papillary cancer haemogram":1,
"dose volume parameters":1,
"radiation therapy":1,
"Chest wall":1,
"Follicular thyroid carcinoma":1,
"Lymph node":1,
"Clear cell renal cell carcinoma":1,
"Metastases":2,
"Differentiated thyroid carcinomas":1,
"Follow-up":1,
"Growth kinetics":1,
"Growth rates":1,
"Thyroid adenomas":1,
"Thyroid carcinomas":1,
"Tumor growth":1,
"Parathyroid adenocarcinoma,":1,
"asymptomatic,":1,
"intrathyroidal,":1,
"normocalcemic":1,
"cancer treatment":1,
"curability and cancer epidemiology":1,
"theragnostics":1,
"nerves":1,
"neurotrophin":1,
"proNGF":2,
"Polymerase chain reaction":1,
"Proto-oncogene proteins B-raf":1,
"Biomarker":1,
"Biopsy-rinse":1,
"Serum":1,
"Conventional ultrasound":1,
"Thyroid micro-nodules":1,
"Ultrasonic elastography":1,
"2019":1,
"CT scan":2,
"Calcitonin":1,
"Carcinoembryonic antigen":1,
"Chromogranin A":1,
"Fine needle aspiration biopsy":1,
"Geriatric":1,
"Goitre":1,
"Goitre (multinodular)":1,
"Histopathology":1,
"Italy":1,
"Lymph node dissection":1,
"Male":1,
"New disease or syndrome: presentations/diagnosis/management":1,
"November":1,
"Oncology":1,
"PET scan":1,
"Radioiodine":1,
"S-100 protein*":1,
"TSH":1,
"Thyroid transcription factor-1":1,
"Thyroid ultrasonography":1,
"White":1,
"recombinant human TSH*":1,
"18F-FDG-PET/CT":1,
"PTC":1,
"palliative therapy":1,
"rare distant metastases":1,
"follicular adenoma":1,
"Clinicopathological features":1,
"Standardized incidence ratios":1,
"leukemia":1,
"pediatric cancers":1,
"second malignant neoplasms":1,
"AMPK":1,
"LKB1":1,
"PKA":1,
"mouse models":1,
"Craniofacial":1,
"GEO":1,
"TCGA":1,
"progression-free interval":1,
"lymph nodes posterior to the right recurrent laryngeal nerve":1,
"predict model":1,
"dog":1,
"galectin-3":1,
"oral cavity":1,
"MTDH":1,
"MiR-136-5p":1,
"microRNA microarray and microRNA-sequencing":1,
"endoscopic surgery":1,
"minimally invasive video-assisted technique":1,
"parapharyngeal lymph node metastases":1,
"parapharyngeal space":1,
"Papillary thyroid carcinoma (PTC)":2,
"Pre-sternal":1,
"Retrosternal":1,
"Substernal":1,
"Biopsy":1,
"Fine-needle":1,
"Thyroid neoplasms":1,
"lymphatic metastasis":1,
"melatonin":1,
"melatonin receptor":1,
"miR-3619-3p":1,
"COX7A1":1,
"Methylation":1,
"breast invasive carcinoma":1,
"methylation-driven genes":1,
"cluster miR-17-92":1,
"differentiation":1,
"miR-19a":1,
"poor prognosis":1,
"Granular cell tumor":1,
"head and neck":1,
"Clinical outcome":1,
"pediatric differentiated thyroid carcinoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年11月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
